The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...

The Food and Drug Administration said it has appointed former biotech executive George Tidmarsh as the agency's top drug ...

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

In announcing his new Commissioner's National Priority Voucher (CNPV) program, FDA Commissioner Marty Makary, MD, MPH, described it as "a common-sense approach" intended "to bring more cures and ...

FDA Commissioner Marty Makary reportedly tried to decline approval for a rare disease drug application from KalVista Pharmaceuticals (KALV) last week. Read more here.

Makary said the vouchers will be given to some drug companies to help streamline the review processthat can take up to a year and bring it down to just one month.

FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review process, using AI tools more, and increasing transparency and clarity ...

FILE - Food and Drug Administration (FDA) commissioner Marty Makary speaks during a news conference at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025.

FDA Commissioner Marty Makary committed to Sen. Josh Hawley that the agency will conduct a safety review of the abortion pill mifepristone.